Lumicks
LUMICKS develops and manufactures high-resolution instruments for cell avidity and dynamic single-molecule analysis. Its products, such as the Avidion and C-Trap, enable researchers to measure the binding strength between cells and study molecular interactions like DNA repair and protein folding in real-time. The company serves academic and pharmaceutical communities focused on immuno-oncology, cell therapy, and molecular biology.
Life Sciences
Biotechnology
Healthtech
Pharmaceuticals
Funding summary
- Total raised
- €97.3M
- Funding rounds
- 2
Investors in Lumicks
Investors on record for Lumicks. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Lumicks?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors